5 United States Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales ( Volume ) by Application ( 2012-2017 ) 5.1 United States Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales and Market Share by Application ( 2012-2017 ) 5.2 United States Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales Growth Rate by Application ( 2012-2017 ) 5.3 Market Drivers and Opportunities
6 United States Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Manufacturers Profiles / Analysis 6.1 GSK 6.1.1 Company Basic Information , Manufacturing Base and Competitors 6.1.2 Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Product Type , Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 GSK Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales , Revenue , Price and Gross Margin ( 2012-2017 ) 6.1.4 Main Business / Business Overview 6.2 Novartis 6.2.2 Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Product Type , Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Novartis Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales , Revenue , Price and Gross Margin ( 2012-2017 ) 6.2.4 Main Business / Business Overview 6.3 Boehringer Ingelheim 6.3.2 Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Product Type , Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales , Revenue , Price and Gross Margin ( 2012-2017 ) 6.3.4 Main Business / Business Overview 6.4 Sunovion Pharmaceuticals 6.4.2 Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Product Type , Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales , Revenue , Price and Gross Margin ( 2012-2017 ) 6.4.4 Main Business / Business Overview 6.5 Perforomist 6.5.2 Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Product Type , Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Perforomist Chronic Obstructive Pulmonary Disease ( COPD ) Drugs Sales , Revenue , Price and Gross Margin ( 2012-2017 )